LFA Resources for Media Regarding FDA Decision on Benlysta®
The following resources are provided by the Lupus Foundation of America to bonafide news organizations regarding the FDA's decision on Benlysta® as a treatment for systemic lupus.
- LFA National Press Release
- Multimedia News Release
- Infographics about lupus, barriers to lupus drug development, and LFA resources for people with lupus and their families
- Read LFA Answers to Frequently Asked Questions about Benlysta
- Video statement by Sandra C. Raymond, LFA President & CEO
- Video statements by Gary S. Gilkeson, MD, Chair of the LFA Medical-Scientific Advisory Council and Joan T. Merrill, MD, LFA Medical Director
- Video statement by Kelly Jean Drury on what the FDA approval of Benlysta means for people with lupus
- General LFA Press Kit
- Lupus Fact Sheet
- Facts and Statistics
- Fact Sheet about the Lewin Group Report on Overcoming Barriers to Drug Development in Lupus (PDF)